Senores Pharmaceuticals Limited IPO Key Performance Indicators and ratios

Senores Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Senores Pharmaceuticals IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE
The Company Key Performance Indicates the pre-issue EPS of ₹12.21 and post-issue EPS of ₹7.10 for FY24. The pre-issue P/E ratio is 32.02x, while the post-issue P/E ratio is 55.05x against the Industry P/E ratio is 39x. The company's ROCE for FY24 is 11.73%, ROE for FY24 is 23.60% and RoNW 23.60%. The Annualised EPS based on the latest financial data is ₹14.4 and PE ratio is 27.15x. These metrics suggest that the IPO is fairly priced.

Key Performance Indicator
KPI	Values
EPS Pre IPO (Rs.)	₹12.21
EPS Post IPO (Rs.)	₹7.10
P/E Pre IPO	32.02
P/E Post IPO	55.05
ROE	23.60%
ROCE	11.73%
P/BV	2.27
Debt/Equity	1.07
RoNW	23.60%